Skip to main content
Full access
Research Article
Published Online: 1 January 2012

Psychopharmacology in Pregnancy and Postpartum

Abstract

Psychiatric illness can occur during pregnancy and the postpartum period. Not only will the mother feel distressed but also these illnesses can cause direct and indirect harm to the baby as well as create long-term negative consequences

Abstract

Psychiatric illness can occur during pregnancy and the postpartum period. Not only will the mother feel distressed but also these illnesses can cause direct and indirect harm to the baby as well as create long-term negative consequences for the mother and the couple. Although using medication during pregnancy or breastfeeding may worry some patients and physicians, untreated depression, anxiety, or psychoses may cause even more harm. Research on the effects of psychotropic drugs on the fetus and on breastfeeding is limited by the inability to establish gold standard trials. Research that is published must also be viewed critically because poor methodologies can lead to unwarranted and alarming conclusions. To date, available information suggests that most antidepressants do not cause major clinical malformations but do cause a slightly elevated risk of miscarriage and preterm delivery. Typical antipsychotics also appear to be relatively safe to use during pregnancy. Less information is available about atypical antipsychotics, but no specific patterns of harm have been detected. Valproic acid has a high risk of causing malformations. Most psychotropic medications are compatible with breastfeeding. The clinician must use the evidence available to make risk/benefit analyses about the best course of action. Educating the mother about what information is available assists her in making decisions that will be of most benefit to her and her baby.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

History

Published online: 1 January 2012
Published in print: Winter 2012

Authors

Affiliations

Gail Erlick Robinson, M.D., D.Psych, FRCPC

Notes

Address correspondence to Dr. Gail Erlick Robinson, Toronto General Hospital, 8-231 EN, 200 Elizabeth St., Toronto, ON, Canada M5G2C4.

Funding Information

Author Information and CME Disclosure
Gail Erlick Robinson, M.D., D.Psych, FRCPC, Department of Psychiatry, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Dr. Robinson reports no competing interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share